We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+6.94%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$54.2B
AUM Growth
+$30.1B
(+125%)
Cap. Flow
+$28.6B
Cap. Flow
% of AUM
52.81%
Top 10 Holdings %
Top 10 Hldgs %
15.56%
Holding
4,600
New
1,635
Increased
1,281
Reduced
635
Closed
782
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.08B |
| 2 |
Amazon
AMZN
|
+$1B |
| 3 |
Meta Platforms (Facebook)
META
|
+$844M |
| 4 |
Apple
AAPL
|
+$842M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$725M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Accenture
ACN
|
+$192M |
| 2 |
West Pharmaceutical
WST
|
+$107M |
| 3 |
Advanced Micro Devices
AMD
|
+$97.2M |
| 4 |
Bio-Rad Laboratories Class A
BIO
|
+$79.3M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$79.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.77% |
| 2 | Healthcare | 17.47% |
| 3 | Financials | 15.58% |
| 4 | Consumer Discretionary | 12.3% |
| 5 | Communication Services | 8.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
Lear
LEA
$6.54B
| $38.6M | 0.07% |
210,984
+169,553
| +409% | +$29.8M |
|
277
Medtronic
MDT
$109B
| $38.5M | 0.07% |
372,134
+221,428
| +147% | +$25.6M |
|
278
Performance Food Group
PFGC
$18B
| $38.5M | 0.07% |
838,518
+824,351
| +5,819% | +$37.5M |
|
279
Roku
ROKU
$21.5B
| $38.3M | 0.07% |
167,799
+8,574
| +5% | +$2.31M |
|
|
NUAN
280
DELISTED
Nuance Communications, Inc.
NUAN
| $38.2M | 0.07% |
691,345
+74,562
| +12% | +$4.11M |
|
281
MakeMyTrip
MMYT
$5.36B
| $38.2M | 0.07% |
1,377,705
+1,356,621
| +6,434% | +$40.4M |
|
282
Xenon Pharmaceuticals
XENE
$6.06B
| $38.1M | 0.07% |
1,220,957
+1,191,154
| +3,997% | +$35.6M |
|
283
Bruker
BRKR
$9.57B
| $38.1M | 0.07% |
454,376
-276,682
| -38% | -$22.2M |
|
|
CPUH
284
DELISTED
Compute Health Acquisition Corp.
CPUH
| $38M | 0.07% |
3,910,094
+1,568,261
| +67% | +$15.3M |
|
285
Verisk Analytics
VRSK
$25.4B
| $37.8M | 0.07% |
165,468
+163,832
| +10,014% | +$35.7M |
|
286
Lennar Class A
LEN
$19.8B
| $37.8M | 0.07% |
335,698
+247,397
| +280% | +$25.3M |
|
287
Flywire
FLYW
$1.98B
| $37.6M | 0.07% |
+988,002
| New | +$42.3M |
|
|
CRHC
288
DELISTED
Cohn Robbins Holdings Corp.
CRHC
| $37.1M | 0.07% |
3,769,597
| – | – |
|
289
McKesson
MCK
$100B
| $37M | 0.07% |
+149,031
| New | +$32.7M |
|
290
CALL
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$15.9B
| $36.9M | 0.07% |
424,200
-79,000
| -16% | -$6.85M |
|
291
Copart
CPRT
$27B
| $36.9M | 0.07% |
+973,600
| New | +$36.1M |
|
292
Parker-Hannifin
PH
$123B
| $36.4M | 0.07% |
+114,291
| New | +$35.4M |
|
|
FRC
293
DELISTED
First Republic Bank
FRC
| $36.3M | 0.07% |
175,986
+109,513
| +165% | +$23.1M |
|
294
Murphy USA
MUSA
$11.2B
| $36.3M | 0.07% |
182,305
+137,549
| +307% | +$24.6M |
|
295
Wyndham Hotels & Resorts
WH
$5.56B
| $36.2M | 0.07% |
+404,306
| New | +$33.8M |
|
296
GoodRx Holdings
GDRX
$1.04B
| $35.6M | 0.07% |
1,088,498
+102,426
| +10% | +$4.12M |
|
|
CONX
297
DELISTED
CONX Corp. Class A Common Stock
CONX
| $35.5M | 0.07% |
3,618,769
+355
| +0% | +$3.49K |
|
298
Carnival Corporation Ltd
CCL
$38.1B
| $35.3M | 0.07% |
1,752,527
+543,048
| +45% | +$11.6M |
|
299
Vulcan Materials
VMC
$34.8B
| $35.2M | 0.07% |
+169,533
| New | +$32.8M |
|
300
Citigroup
C
$222B
| $35M | 0.06% |
579,844
+408,922
| +239% | +$27.2M |
|
Similar funds
Marshall Wace's Q4 2021 Portfolio in Review
As of Q4 2021, Marshall Wace held 4,600 positions worth $54.2B, up 125% from $24.1B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Marshall Wace deployed $28.6B of net new capital in Q4 2021, opening 1,635 new positions and adding to 1,281 existing holdings. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 1,140,732 shares worth $542M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Accenture, an estimated $192M trimmed.
- Marshall Wace's largest Q4 2021 buy was State Street SPDR S&P 500 ETF Trust: 1,140,732 shares worth $542M.
- Marshall Wace added most to Microsoft in Q4 2021, an estimated $1.08B increase.
- Marshall Wace's biggest Q4 2021 reduction was Accenture, cutting an estimated $192M.
- Marshall Wace fully exited Sabre in Q4 2021, selling an estimated $44.1M.
- Marshall Wace's ten largest holdings make up 16% of its $54.2B portfolio in Q4 2021.
- Marshall Wace opened 1,635 new positions and closed 782 in Q4 2021.
- Marshall Wace's portfolio value rose 125% quarter-over-quarter to $54.2B.
Based on Marshall Wace's 13F filing for Q4 2021, filed 14 Feb 2022.